| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |